Overview of the Patent
Especially patients with clinically manifest arteriosclerosis can be treated that are currently being treated with invasive methods such as stents or with pharmaceuticals with the goal to improve the bloodflow or to inhibit coagulation.
Usually these patients must take additional drugs for the treatment of concomitant diseases (i.e., hypertension, hypercholesterolemia, chronic vascular inflammation) to prevent further impairment of the disease.
A treatment with the drug could be initiated after careful evaluation of risk / medical benefit also as a preventive measure, i.e. patients over 50 years.